En Es
Categories

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent focuses its products and solutions on six key markets: Food, Environmental and Forensics, Pharmaceutical, Diagnostics, Chemical and Energy, and Researc ...
Silver member
Products Covid-19NewsSummary
Close

Covid-19 AGILENT

Clinical Laboratory

SARS-CoV-2 qRT-PCR IVD Reagent Kit
SARS-CoV-2 qRT-PCR Dx Kit (CE-IVD)

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. The CE-IVD marked kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens obtained from individuals suspected of having COVID-19 by their healthcare provider. The kit is validated for use with multiple automated RNA extraction systems and real-time PCR instruments and allows clinical laboratories to easily generate diagnostic results from this single-tube assay. • The Agilent SARS-CoV-2 qRT-PCR Dx kit is CE-IVD marked in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC. • For In Vitro Diagnostic Use
More details

Real-time PCR System
AriaMx Real-time PCR System

The AriaMx Real-Time PCR system is a fully integrated qPCR solution for amplification, detection, and data analysis, combining a novel thermal cycler, an advanced optical system with LED excitation source, and comprehensive data analysis software. AriaMx has a closed-tube PCR detection format and can be used with many fluorescence detection chemistries, including SYBR Green and EvaGreen dyes, and fluorogenic probe systems such as TaqMan. Functional reporting, more than 120 attributes, and built-in diagnostics assist in troubleshooting. A modular and flexible design with intuitive touch-screen interface improves productivity.
More details
Close

News of AGILENT

Agilent Technologies expande su portafolio con la compra de BioTek Instruments

25 Jul 2019
Agilent Technologies expande su portafolio con la compra de BioTek Instruments
Agilent Technologies Inc. (Santa Clara, CA, EUA), un líder mundial en los mercados de ciencias de la vida, diagnóstico y químicos aplicados, firmó un acuerdo definitivo para adquirir BioTek Instruments (Winooski, VT, EUA) una empresa de propiedad privada, que diseña, fabrica y distribuye instrumentos innovadores para las ciencias de la vida. La adquisición de BioTek hace que Agilent esté bien posicionada en los mercados grandes y crecientes de inmunooncología e inmunoterapia y expande la presencia de la compañía en biofarma, la academia y la investigación. La combinación permitirá admitir nuevos flujos de trabajo que podrán revelar información más completa para el análisis de células en vivo. 
Read More

Agilent Technologies Expands Portfolio with Acquisition of BioTek Instruments

17 Jul 2019
Agilent Technologies Expands Portfolio with Acquisition of BioTek Instruments
Agilent Technologies Inc., a global leader in the life sciences, diagnostics and applied chemical markets, has signed a definitive agreement to acquire privately-owned BioTek Instruments, which designs, manufactures, and distributes innovative life science instrumentation.
Read More

Agilent Technologies to Acquire Multiplicom

03 Jan 2017
Agilent Technologies to Acquire Multiplicom
Agilent Technologies Inc. has entered into a definitive agreement to acquire European diagnostics company Multiplicom N.V., for approximately EUR 68 million in cash.
Read More
Close

About AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent focuses its products and solutions on six key markets: Food, Environmental and Forensics, Pharmaceutical, Diagnostics, Chemical and Energy, and Research.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 qRT-PCR IVD Reagent Kit

SARS-CoV-2 qRT-PCR IVD Reagent Kit

Model: SARS-CoV-2 qRT-PCR Dx Kit (CE-IVD)
Request Information

Description:

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. The CE-IVD marked kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control.
Read More

Full Description Features Specifications

Description

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. The CE-IVD marked kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens obtained from individuals suspected of having COVID-19 by their healthcare provider. The kit is validated for use with multiple automated RNA extraction systems and real-time PCR instruments and allows clinical laboratories to easily generate diagnostic results from this single-tube assay.

• The Agilent SARS-CoV-2 qRT-PCR Dx kit is CE-IVD marked in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC.

• For In Vitro Diagnostic Use Request Information

Features

• Single-tube qRT-PCR assay includes 3 targets: N1 and N23 viral targets and human RNase P
• Single tube assay minimizes use of consumables and maximizes sample throughput per instrument run
• Available as an optional stand-alone positive control
• Developed using primer and probe sequences published by the U.S. Centers for Disease Control (CDC)2
• Clinically validated and demonstrated with a limit of detection as low as 1.5 copies per µL
• Choose from two automated RNA extraction platforms
• Protocols for established 96-well real-time PCR systems for easy assay adoption on existing instruments Request Information

Specifications

• Kit throughout: Validated protocols for 96 well plate formats
• Platform: CFX96 Touch Real-Time PCR Detection System (Bio-Rad)/Applied Biosystems 7500 Fast Real-Time PCR Instrument (Thermo Fisher Scientific)/AriaDx Real-Time PCR Instrument
• Primary Sample Type: Nasopharyngeal swab specimen/Nasal swab specimen/Oropharyngeal swab specimen
• Primer/Probe Sequences: Published by the U.S. Centers for Disease Control (CDC)
• Qualitative Reaction Speed: Fast Cycling
• Reaction Format: Single tube
• SARS-CoV-2 Viral RNA Controls: In-vitro transcribed N1 RNA/In-vitro transcribed N2 RNA
• SARS-CoV-2 Viral RNA Primer/Probes: N1/N2
• Sample Reaction Internal Control Primer/probe: Human RNAse P
• Sensitivity: Limit of detection (LoD) as low as 1.5 copies per µL ng
• Target Specificity: No cross-reactivity with 20 human respiratory pathogens, based on target sequences
• Technique: qPCR
• Validated RNA Extraction Systems and Reagents: MagMAX Viral/Pathogen II (MVP II) Nucleic Acid Isolation Kit with Automated KingFisher Flex system (Thermo Fisher Scientific); QIASymphony DSP Virus/Pathogen Midi Kit with automated QiaSymphony SP (Qiagen). Request Information

Send A Message To This Supplier

* Required Information
* Email
To
AGILENT (SARS-CoV-2 qRT-PCR IVD Reagent Kit)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions